Who makes [14C]- Rongliflozin?

[14C]- Rongliflozin is developed by Sunshine Lake Pharma Co., Ltd..

What development phase is [14C]- Rongliflozin in?

[14C]- Rongliflozin is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[14C]- Rongliflozin

Sunshine Lake Pharma Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	[14C]- Rongliflozin
Sponsor	Sunshine Lake Pharma Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]- Rongliflozin CI brief — competitive landscape report
[14C]- Rongliflozin updates RSS · CI watch RSS
Sunshine Lake Pharma Co., Ltd. portfolio CI